Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.

Clinical trial NCT05593419 · UNKNOWN

Trial details

NCT number: NCT05593419
Sponsor: Peking University
Status: UNKNOWN
Study type: OBSERVATIONAL

Gastric Cancer Patients Received Immunotherapy

Start date: 2022-10-31
Primary completion: 2025-10-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.